{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T21:00:58Z","timestamp":1774386058647,"version":"3.50.1"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360315"],"award-info":[{"award-number":["82360315"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore the pharmacotherapeutic efficacy of heparin in the management of meconium-induced acute lung injury (ALI) in near-term newborn rabbits subjected to mechanical ventilation (MV) and ancillary respiratory medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Newborn rabbits at 30-day gestation (term 31 days) were anesthetized, intratracheally intubated and received human meconium-saline suspension, followed by parallel MV with individually adjusted tidal volume in a multi-plethysmograph-ventilator system. When ALI was induced after initial 3-h MV, therapeutic effects of single or combined subcutaneous heparin (100 U\/kg), surfactant (200 mg\/kg), and inhaled nitric oxide (iNO, 10 ppm), were compared for lung protective ventilation and survival as outcome, analyzed with linear regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Significantly reduced respiratory compliance by meconium was reinstalled during ensuing 7-h MV, with improved survival, among the treatment groups. The impact was verified by lung injury severity, surfactant phospholipid pools, and multiple mRNA expressions of surfactant proteins, lung fluid clearance-related factors, inflammatory mediators, growth factors, endothelial cell injury and coagulation-related factors as subphenotyping biomarkers. The overall benefits of heparin alone, or exerted with the dual and triple regimens, were discernible by both generalized linear model and Cox proportional hazard ratio regression for survival and other major variables as outcome. Its adverse effects were intangible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The comparable efficacy of heparin, alongside the PS and NO, was corroborated in attenuating meconium-mediated, ventilator-induced ALI, which should warrant clinical investigation to validate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0345718","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:32:21Z","timestamp":1774373541000},"page":"e0345718","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of heparin in respiratory support of near-term rabbits with meconium-induced acute lung injury: Linear regression model analyses"],"prefix":"10.1371","volume":"21","author":[{"given":"Siyu","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiyin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8095-4159","authenticated-orcid":true,"given":"Xiaojing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1473-3558","authenticated-orcid":true,"given":"Bo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"10","key":"pone.0345718.ref001","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41372-023-01708-2","article-title":"Meconium aspiration syndrome: a comprehensive review","volume":"43","author":"A Osman","year":"2023","journal-title":"J Perinatol"},{"issue":"4","key":"pone.0345718.ref002","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.siny.2017.04.002","article-title":"Meconium \u201caspiration\u201d (or respiratory distress associated with meconium-stained amniotic fluid?)","volume":"22","author":"NE Vain","year":"2017","journal-title":"Semin Fetal Neonatal Med"},{"key":"pone.0345718.ref003","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.105.1.14","article-title":"Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes","volume":"105","author":"MC Walsh-Sukys","year":"2000","journal-title":"Pediatrics"},{"key":"pone.0345718.ref004","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/B978-0-323-69415-5.00013-8","article-title":"Pulmonary hypertension of the newborn.","volume-title":"Principles of Neonatology","author":"P Chandrasekharan","year":"2024","edition":"1"},{"issue":"9","key":"pone.0345718.ref005","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199702273360901","article-title":"Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure","volume":"336","author":"Neonatal Inhaled Nitric Oxide Study Group","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0345718.ref006","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/antiox12010037","article-title":"Time-Dependent Oxidative Alterations in Plasma and Lung Tissue after Meconium Aspiration in a Rabbit Model","volume":"12","author":"P Kosutova","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"pone.0345718.ref007","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1164\/ajrccm.154.3.8810617","article-title":"Exogenous surfactant improves ventilation efficiency and alveolar expansion in rats with meconium aspiration","volume":"154","author":"B Sun","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"pone.0345718.ref008","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1152\/jappl.1994.77.4.1961","article-title":"Exogenous surfactant improves lung compliance and oxygenation in adult rats with meconium aspiration","volume":"77","author":"B Sun","year":"1994","journal-title":"J Appl Physiol (1985)"},{"issue":"5","key":"pone.0345718.ref009","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jpeds.2006.07.027","article-title":"Surfactant phosphatidylcholine metabolism in neonates with meconium aspiration syndrome","volume":"149","author":"DJ Janssen","year":"2006","journal-title":"J Pediatr"},{"issue":"1","key":"pone.0345718.ref010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000528914","article-title":"European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update","volume":"120","author":"DG Sweet","year":"2023","journal-title":"Neonatology"},{"issue":"7","key":"pone.0345718.ref011","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/PCC.0000000000002961","article-title":"Epidemiology of Neonatal Acute Respiratory Distress Syndrome: Prospective, Multicenter, International Cohort Study","volume":"23","author":"D De Luca","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"pone.0345718.ref012","article-title":"Pulmonary specific ancillary treatment for pediatric acute respiratory distress syndrome: from the second pediatric acute lung injury consensus conference","volume":"24","author":"Second Pediatric Acute Lung Injury Consensus Conference of the Pediatric Acute Lung I","year":"2023","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"pone.0345718.ref013","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13054-021-03489-6","article-title":"Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps","volume":"25","author":"D De Luca","year":"2021","journal-title":"Crit Care"},{"key":"pone.0345718.ref014","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpeds.2018.11.041","article-title":"Surfactant Administration in Preterm Infants: Drug Development Opportunities","volume":"208","author":"G Taylor","year":"2019","journal-title":"J Pediatr"},{"key":"pone.0345718.ref015","article-title":"Surfactant therapy and antibiotics in neonates with meconium aspiration syndrome: a systematic review and meta-analysis","author":"CK Natarajan","year":"2016","journal-title":"J Perinatol"},{"issue":"1","key":"pone.0345718.ref016","article-title":"Nitric oxide for respiratory failure in infants born at or near term","volume":"1","author":"KJ Barrington","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0345718.ref017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.niox.2019.12.001","article-title":"Inhaled nitric oxide use in neonates: Balancing what is evidence-based and what is physiologically sound","volume":"95","author":"LG Sherlock","year":"2020","journal-title":"Nitric Oxide"},{"issue":"2","key":"pone.0345718.ref018","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/pharmrev.122.000684","article-title":"Pharmacology of Heparin and Related Drugs: An Update","volume":"75","author":"J Hogwood","year":"2023","journal-title":"Pharmacol Rev"},{"key":"pone.0345718.ref019","doi-asserted-by":"crossref","DOI":"10.1097\/01.CCM.0000057846.21303.AB","article-title":"Coagulation, fibrinolysis, and fibrin deposition in acute lung injury","volume":"31","author":"S Idell","year":"2003","journal-title":"Critical Care Medicine"},{"issue":"9","key":"pone.0345718.ref020","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1183\/09031936.97.10091967","article-title":"Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A","volume":"10","author":"B Sun","year":"1997","journal-title":"Eur Respir J"},{"issue":"10","key":"pone.0345718.ref021","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1055\/s-0040-1715460","article-title":"The Anticoagulant and Nonanticoagulant Properties of Heparin","volume":"120","author":"DMH Beurskens","year":"2020","journal-title":"Thromb Haemost"},{"issue":"10","key":"pone.0345718.ref022","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3390\/ph17101362","article-title":"Multifaceted Heparin: Diverse Applications beyond Anticoagulant Therapy","volume":"17","author":"R Sultana","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"pone.0345718.ref023","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1038\/s41390-022-02323-1","article-title":"Effects of systemic anticoagulation in a murine model of compensatory lung growth","volume":"93","author":"LJ Yu","year":"2023","journal-title":"Pediatr Res"},{"issue":"1","key":"pone.0345718.ref024","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbrc.2019.11.041","article-title":"Heparin improves alveolarization and vascular development in hyperoxia-induced bronchopulmonary dysplasia by inhibiting neutrophil extracellular traps","volume":"522","author":"Y Sun","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"pone.0345718.ref025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S2213-2600(20)30470-7","article-title":"Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial","volume":"9","author":"B Dixon","year":"2021","journal-title":"Lancet Respir Med"},{"key":"pone.0345718.ref026","first-page":"882","volume-title":"Pediatric and Neonatal Dosage Handbook. A universal resource for clinicians treating pediatric and neonatal patients. American Pharmacists Association. Lexicomp","author":"CK Taketomo","year":"2016","edition":"23"},{"issue":"3","key":"pone.0345718.ref027","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41390-022-02152-2","article-title":"Efficacy of synthetic surfactant (CHF5633) bolus and\/or lavage in meconium-induced lung injury in ventilated newborn rabbits","volume":"93","author":"Y Xu","year":"2023","journal-title":"Pediatr Res"},{"issue":"2","key":"pone.0345718.ref028","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41390-019-0421-9","article-title":"Suppression of pulmonary group B streptococcal proliferation and translocation by surfactants in ventilated near-term newborn rabbits","volume":"86","author":"Y Xu","year":"2019","journal-title":"Pediatr Res"},{"issue":"3","key":"pone.0345718.ref029","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1152\/japplphysiol.00606.2022","article-title":"Efficacy of perinatal pharmacotherapeutic actions for survival of very preterm newborn rabbits at 26-day gestation","volume":"134","author":"M Chen","year":"2023","journal-title":"J Appl Physiol (1985)"},{"issue":"3","key":"pone.0345718.ref030","article-title":"In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits","volume":"15","author":"X Guo","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"pone.0345718.ref031","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1152\/japplphysiol.00027.2021","article-title":"Comparison of survival of preterm newborn rabbits at 25-28 days of gestation with perinatal therapies at birth transition","volume":"131","author":"S Luo","year":"2021","journal-title":"J Appl Physiol (1985)"},{"issue":"5","key":"pone.0345718.ref032","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1152\/jappl.1992.73.5.2089","article-title":"Different ventilation strategies alter surfactant responses in preterm rabbits","volume":"73","author":"ED Rider","year":"1992","journal-title":"J Appl Physiol (1985)"},{"issue":"3","key":"pone.0345718.ref033","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0021-9258(18)70226-3","article-title":"Phosphorus assay in column chromatography","volume":"234","author":"GR Bartlett","year":"1959","journal-title":"J Biol Chem"},{"issue":"3","key":"pone.0345718.ref034","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0022-2275(20)36986-8","article-title":"Isolation of disaturated phosphatidylcholine with osmium tetroxide","volume":"17","author":"RJ Mason","year":"1976","journal-title":"J Lipid Res"},{"issue":"4","key":"pone.0345718.ref035","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/pr.2015.265","article-title":"Meconium-induced inflammation and surfactant inactivation: specifics of molecular mechanisms","volume":"79","author":"J Kopincova","year":"2016","journal-title":"Pediatr Res"},{"issue":"6","key":"pone.0345718.ref036","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0049-3848(97)00285-5","article-title":"Indium-111 DTPA-heparin: pharmacokinetics and biodistribution following subcutaneous administration in rat and rabbit","volume":"88","author":"RW Bunting","year":"1997","journal-title":"Thromb Res"},{"issue":"3","key":"pone.0345718.ref037","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2165\/00003088-198005030-00002","article-title":"Clinical pharmacokinetics of heparin","volume":"5","author":"JW Estes","year":"1980","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"pone.0345718.ref038","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s40262-013-0094-1","article-title":"Pharmacokinetics and pharmacodynamics of anticoagulants in paediatric patients","volume":"52","author":"DL Yee","year":"2013","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"pone.0345718.ref039","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1203\/00006450-198107000-00007","article-title":"Heparin clearance in the newborn","volume":"15","author":"MM McDonald","year":"1981","journal-title":"Pediatr Res"},{"issue":"4","key":"pone.0345718.ref040","article-title":"Unfractionated heparin and enoxaparin reduce high-stretch ventilation augmented lung injury: a prospective, controlled animal experiment","volume":"13","author":"L-F Li","year":"2009","journal-title":"Crit Care"},{"issue":"6","key":"pone.0345718.ref041","doi-asserted-by":"crossref","first-page":"108","DOI":"10.31083\/j.fbl2806108","article-title":"Protective Effect of Unfractionated Heparin on Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Neonatal Mice via the JAK2\/STAT3 Signaling Pathway","volume":"28","author":"J Xiong","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"key":"pone.0345718.ref042","doi-asserted-by":"crossref","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"P Monagle","year":"2012","journal-title":"Chest"},{"issue":"12","key":"pone.0345718.ref043","article-title":"Surfactant for meconium aspiration syndrome in term and late preterm infants","volume":"2014","author":"AI El Shahed","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"pone.0345718.ref044","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0008-6363(02)00327-9","article-title":"Vasoprotection by nitric oxide: mechanisms and therapeutic potential","volume":"55","author":"MT Gewaltig","year":"2002","journal-title":"Cardiovasc Res"},{"issue":"10","key":"pone.0345718.ref045","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1097\/00003246-199710000-00027","article-title":"Effect of nitric oxide in meconium aspiration syndrome after treatment with surfactant","volume":"25","author":"K Rais-Bahrami","year":"1997","journal-title":"Crit Care Med"},{"issue":"2","key":"pone.0345718.ref046","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000081266","article-title":"Mitigation of meconium-induced lung injury by surfactant and inhaled nitric oxide is associated with suppression of nuclear transcription factor kappa B","volume":"87","author":"X Hu","year":"2005","journal-title":"Biol Neonate"},{"issue":"6","key":"pone.0345718.ref047","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10753-013-9656-5","article-title":"Unfractionated heparin ameliorates lipopolysaccharide-induced lung inflammation by downregulating nuclear factor-\u03baB signaling pathway","volume":"36","author":"X Li","year":"2013","journal-title":"Inflammation"},{"issue":"3","key":"pone.0345718.ref048","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s10753-014-9812-6","article-title":"Treatment of low molecular weight heparin inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats","volume":"37","author":"Z-G Luan","year":"2014","journal-title":"Inflammation"},{"key":"pone.0345718.ref049","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1164\/ajrccm.158.5.9803041","article-title":"Heparin improves gas exchange during experimental acute lung injury in newborn piglets","volume":"158","author":"K Abubakar","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"pone.0345718.ref050","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s10753-019-01055-5","article-title":"Attenuating Pulmonary Hypertension by Protecting the Integrity of Glycocalyx in Rats Model of Pulmonary Artery Hypertension","volume":"42","author":"J Guo","year":"2019","journal-title":"Inflammation"},{"issue":"11","key":"pone.0345718.ref051","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00006.2016","article-title":"Plasma syndecan-1 and heparan sulfate correlate with microvascular glycocalyx degradation in hemorrhaged rats after different resuscitation fluids","volume":"310","author":"IP Torres Filho","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"pone.0345718.ref052","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/jcb.22543","article-title":"Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual-specificity phosphatase MKP-1","volume":"110","author":"CI Blaukovitch","year":"2010","journal-title":"J Cell Biochem"},{"issue":"1","key":"pone.0345718.ref053","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1164\/ajrccm\/145.1.193","article-title":"Partial reversal of hypoxic pulmonary hypertension by heparin","volume":"145","author":"PM Hassoun","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"pone.0345718.ref054","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1164\/ajrccm.149.6.8004307","article-title":"Inhibition of hypoxic pulmonary hypertension by heparins of differing in vitro antiproliferative potency","volume":"149","author":"BT Thompson","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"pone.0345718.ref055","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/01.RES.0000188211.83193.1a","article-title":"Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1\/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice","volume":"97","author":"L Yu","year":"2005","journal-title":"Circ Res"},{"key":"pone.0345718.ref056","article-title":"Low molecular weight heparin and unfractionated heparin are both effective at accelerating pulmonary vascular maturation in neonatal rabbits","author":"SB O\u2019Blenes","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"pone.0345718.ref057","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/cells8050471","article-title":"Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology","volume":"8","author":"RG Akwii","year":"2019","journal-title":"Cells"},{"issue":"6","key":"pone.0345718.ref058","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1042\/BST20110699","article-title":"Molecular control of angiopoietin signalling","volume":"39","author":"H Singh","year":"2011","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"pone.0345718.ref059","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/jcm11030557","article-title":"Ventilation-Induced Lung Injury (VILI) in Neonates: Evidence-Based Concepts and Lung-Protective Strategies","volume":"11","author":"R Kalikkot Thekkeveedu","year":"2022","journal-title":"J Clin Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:32:31Z","timestamp":1774373551000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345718"}},"subtitle":[],"editor":[{"given":"Elsayed","family":"Abdelkreem","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0345718","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}